Integrating AI into modern pharmaceutics bridging formulation and predictive modeling
1Devesh Pravinkumar Bhavsar*
KES’s Late Shri P.C.B.College of D.Pharmacy & Late Prof. R.K. Kele College of B.Pharmacy, Amalner - 425401 (India)
ABSTRACT
The rapid evolution of artificial intelligence (AI) has opened transformative opportunities in pharmaceutical sciences, particularly within the domain of pharmaceutics. Traditionally, formulation development has relied on empirical experimentation and iterative optimization, often constrained by time, cost, and variability in outcomes. Modern pharmaceutics, however, is witnessing a paradigm shift as AIdriven tools enable predictive modeling, data-driven decision-making, and intelligent design of dosage forms. This paper explores the integration of AI into pharmaceutics, emphasizing its dual role in formulation development and forecasting performance outcomes. On the formulation side, AI algorithms such as machine learning and deep learning are increasingly applied to predict excipient compatibility, optimize drug release kinetics, and design advanced delivery systems including nanoparticles, liposomes, and controlled-release matrices. By analyzing large datasets from preformulation studies, AI can reduce experimental redundancy and accelerate the identification of optimal formulation parameters. On the forecasting side, predictive modeling offers significant advantages in anticipating product stability, bioavailability, and therapeutic efficacy, while also supporting industrial scale-up and technology transfer. AI-enabled simulations can forecast dissolution profiles, pharmacokinetic behavior, and patient-centric outcomes, thereby bridging laboratory innovation with industrial application and regulatory compliance. The paper highlights emerging applications where AI has successfully enhanced formulation efficiency, minimized resource utilization, and improved reproducibility. Ethical considerations, regulatory challenges, and the need for robust validation frameworks are also discussed, underscoring the importance of responsible AI adoption in pharmaceutical sciences. Ultimately, integrating AI into modern pharmaceutics represents a strategic convergence of experimental science and computational intelligence, offering a pathway toward faster, smarter, and more personalized drug development